Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Dr. Reddy’s earns FDA approval for Doxil generic
Dr. Reddy’s earns FDA approval for Doxil generic
PRINCETON, N.
FDA approves Lupin’s Seroquel XR generic
FDA approves Lupin’s Seroquel XR generic
SILVER SPRING, Md.
Artificial intelligence will reinvent drugs ten times faster people
Artificial intelligence will reinvent drugs ten times faster people
To create a new drug today, scientists have to test tens of thousands of components to understand how they interact.
Astellas completes 800 million euro biotech acquisition
Astellas completes 800 million euro biotech acquisition
Japanese pharma company Astellas has completed its 800 million euro acquision of Ogeda.
Teva Pharmaceutical's search committee recommends foreign CEO: report
Teva Pharmaceutical's search committee recommends foreign CEO: report
Teva Pharmaceutical Industries' (TEVA.
Shire's swelling disorder drug moves closer to U.S. approval
Shire's swelling disorder drug moves closer to U.S. approval
Successful late-stage data on Shire Plc's, long-acting preventative treatment for hereditary angioedema (HAE) brings the Dublin-based drugmaker one step closer to U.
Biogen pays $120 million for late-stage stroke treatment Cirara
Biogen pays $120 million for late-stage stroke treatment Cirara
Biogen has licensed a late-stage stroke drug that could be the first treatment advance in the therapy area since the 1990s.
Pfizer drug from Medivation deal shows promise in breast cancer: study
Pfizer drug from Medivation deal shows promise in breast cancer: study
A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in ch...
India's drug pricing regulator clamps down on drug cocktails
India's drug pricing regulator clamps down on drug cocktails
India's drug pricing regulator has demanded explanations from 65 domestic and global drugmakers for selling new forms of essential diabetes and antibiotic drugs without its approval.
Merck KGaA eyes options for splitting-out divisions
Merck KGaA eyes options for splitting-out divisions
German life sciences group Merck KGaA (MRK.
Bayer obtained FDA priority review for cancer drug
Bayer obtained FDA priority review for cancer drug
German drugmaker Bayer won the U.
European Medicines Agency issued its 2016 annual report
European Medicines Agency issued its 2016 annual report
The European Medicines Agency (EMA) published 2016 annual report.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand